{"transactions":[{"id":717201,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T20:15:21.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":32341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) July 1, 2027 or (ii) the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."}],"balance_after":32341,"derivative":{"exercise_price":18.48,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":32341},"source":{"system":"sec-edgar","filing":"0001193125-26-294556","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000119312526294556/ownership.xml","form_type":"4"}},{"id":1094265,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:43:01.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."}],"balance_after":21000,"derivative":{"exercise_price":14.47,"expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000950170-25-093098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000095017025093098/ownership.xml","form_type":"4"}},{"id":1466998,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T20:05:07.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) June 26, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board."}],"balance_after":21000,"derivative":{"exercise_price":12.31,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000950170-24-079037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000095017024079037/ownership.xml","form_type":"4"}},{"id":1851372,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T23:54:28.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service on the Board."}],"balance_after":20000,"derivative":{"exercise_price":27.67,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-23-028725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000095017023028725/ownership.xml","form_type":"4"}},{"id":2061774,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2023-01-05T20:26:25.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":44600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares underlying this option vest as to 25% of the shares on January 3, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":44600,"derivative":{"exercise_price":5.73,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":44600},"source":{"system":"sec-edgar","filing":"0001562180-23-000255","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023000255/primarydocument.xml","form_type":"4"}},{"id":2061773,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-01-05T20:26:25.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":729,"price":5.4075,"value":3942.0675,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price represents the weighted average price with a low of $5.35 and a high of $5.49. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Represents (i) 21,020 shares of common stock; (ii) 5,500 RSUs from award granted on January 4, 2021; (iii) 9,000 RSUs from award granted on January 3, 2022; and (iv) 22,300 RSUs from award granted on January 3, 2023."}],"balance_after":57820,"source":{"system":"sec-edgar","filing":"0001562180-23-000255","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023000255/primarydocument.xml","form_type":"4"}},{"id":2061772,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-01-05T20:26:25.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":1639,"price":5.5756,"value":9138.4084,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price represents the weighted average price with a low of $5.44 and a high of $5.78. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Represents (i) 20,374 shares of common stock; (ii) 6,875 RSUs from award granted on January 4, 2021; (iii) 9,000 RSUs from award granted on January 3, 2022; and (iv) 22,300 RSUs from award granted on January 3, 2023."}],"balance_after":58549,"source":{"system":"sec-edgar","filing":"0001562180-23-000255","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023000255/primarydocument.xml","form_type":"4"}},{"id":2061771,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-01-05T20:26:25.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":22300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests 25% on January 3, 2024 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 19,013 shares of common stock; (ii) 6,875 RSUs from award granted on January 4, 2021; (iii) 12,000 RSUs from award granted on January 3, 2022; and (iv) 22,300 RSUs from award granted on January 3, 2023."}],"balance_after":60188,"source":{"system":"sec-edgar","filing":"0001562180-23-000255","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218023000255/primarydocument.xml","form_type":"4"}},{"id":2235426,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T11:30:22.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) June 8, 2023 or (ii) the Issuer's 2023 annual meeting of stockholders, subject to Reporting Person's continued service on the Board."}],"balance_after":12500,"derivative":{"exercise_price":12.31,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-22-021804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924322021804/doc4.xml","form_type":"4"}},{"id":2415859,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-02-02T17:20:54.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares underlying this option have vested."}],"balance_after":0,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":333},"source":{"system":"sec-edgar","filing":"0001562180-22-000956","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022000956/primarydocument.xml","form_type":"4"}},{"id":2415858,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T17:20:54.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares underlying this option have vested."}],"balance_after":58000,"derivative":{"exercise_price":4.17,"expiration_date":"2026-05-10","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001562180-22-000956","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022000956/primarydocument.xml","form_type":"4"}},{"id":2415857,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-02-02T17:20:54.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":2000,"price":4.17,"value":8340.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents (i) 17,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022."}],"balance_after":37888,"source":{"system":"sec-edgar","filing":"0001562180-22-000956","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022000956/primarydocument.xml","form_type":"4"}},{"id":2415856,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-02-02T17:20:54.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":333,"price":3.72,"value":1238.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents (i) 15,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022."}],"balance_after":35888,"source":{"system":"sec-edgar","filing":"0001562180-22-000956","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022000956/primarydocument.xml","form_type":"4"}},{"id":2442851,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2022-01-05T20:25:02.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this option vest as to 25% of the shares on January 3, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":53000,"derivative":{"exercise_price":10.69,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0001562180-22-000306","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022000306/primarydocument.xml","form_type":"4"}},{"id":2442850,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-01-05T20:25:02.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":1445,"price":10.6115,"value":15333.6175,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell-to-cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price represents the weighted average price with a low of $10.45 and a high of $10.76. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Represents (i) 15,305 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022."}],"balance_after":35555,"source":{"system":"sec-edgar","filing":"0001562180-22-000306","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022000306/primarydocument.xml","form_type":"4"}},{"id":2442849,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-01-05T20:25:02.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests 25% on January 3, 2023 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 14,000 shares of common stock; (ii) 11,000 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022."}],"balance_after":37000,"source":{"system":"sec-edgar","filing":"0001562180-22-000306","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218022000306/primarydocument.xml","form_type":"4"}},{"id":2632943,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-15T20:24:38.000Z","date":"2021-07-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vest monthly over a three year period, subject to Reporting Person's continued service on the Board."}],"balance_after":25000,"derivative":{"exercise_price":17.88,"expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-028495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000089924321028495/doc4.xml","form_type":"4"}},{"id":2808142,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-03-04T16:54:58.000Z","date":"2021-03-03","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":333,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001562180-21-001982","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218021001982/primarydocument.xml","form_type":"4"}},{"id":2808141,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-03-04T16:54:58.000Z","date":"2021-03-03","kind":"exercise","acquired":true,"shares":3000,"price":3.72,"value":11160.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents 14,000 shares of common stock and 11,000 restricted stock units"}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001562180-21-001982","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218021001982/primarydocument.xml","form_type":"4"}},{"id":2918951,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-01-05T18:25:27.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":58000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest as to 25% of the shares on January 4, 2022, with the remainder vesting in 36 equal installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":58000,"derivative":{"exercise_price":18.07,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":58000},"source":{"system":"sec-edgar","filing":"0000899243-21-000474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000089924321000474/doc4.xml","form_type":"4"}},{"id":2918950,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-01-05T18:25:27.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests 25% on January 4, 2022 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 11,000 shares of common stock and 11,000 restricted stock units."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0000899243-21-000474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000089924321000474/doc4.xml","form_type":"4"}},{"id":3208266,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-03-16T07:00:44.000Z","date":"2020-03-13","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares underlying this option have vested."}],"balance_after":3333,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001562180-20-002529","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218020002529/primarydocument.xml","form_type":"4"}},{"id":3208265,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-03-16T07:00:44.000Z","date":"2020-03-13","kind":"exercise","acquired":true,"shares":2000,"price":3.72,"value":7440.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001562180-20-002529","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218020002529/primarydocument.xml","form_type":"4"}},{"id":3284035,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-02-07T16:14:42.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% of the shares on February 06, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":80000,"derivative":{"exercise_price":21.08,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-20-001005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218020001005/primarydocument.xml","form_type":"4"}},{"id":3302487,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-24T16:58:54.000Z","date":"2020-01-23","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares underlying this option have vested."}],"balance_after":5333,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001562180-20-000559","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218020000559/primarydocument.xml","form_type":"4"}},{"id":3302486,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2020-01-24T16:58:54.000Z","date":"2020-01-23","kind":"exercise","acquired":true,"shares":1000,"price":3.72,"value":3720.0,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001562180-20-000559","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218020000559/primarydocument.xml","form_type":"4"}},{"id":3458383,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-19T21:58:55.000Z","date":"2019-07-18","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vested as to 25% of the shares on December 21, 2016, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":6333,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001562180-19-004017","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218019004017/primarydocument.xml","form_type":"4"}},{"id":3458382,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2019-07-19T21:58:55.000Z","date":"2019-07-18","kind":"exercise","acquired":true,"shares":2000,"price":3.72,"value":7440.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001562180-19-004017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218019004017/primarydocument.xml","form_type":"4"}},{"id":3531164,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2019-05-10T16:26:53.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vested as to 25% of the shares on May 8th, 2020, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":20.91,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-19-002766","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218019002766/primarydocument.xml","form_type":"4"}},{"id":3692593,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-17T17:52:46.000Z","date":"2019-01-17","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vested as to 25% of the shares on December 21, 2016, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":8333,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001562180-19-000344","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218019000344/primarydocument.xml","form_type":"4"}},{"id":3692592,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Common Stock","published_at":"2019-01-17T17:52:46.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":2000,"price":3.72,"value":7440.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001562180-19-000344","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218019000344/primarydocument.xml","form_type":"4"}},{"id":3712631,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-02T17:32:14.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% of the shares on January 02, 2020, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":19.56,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-19-000093","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218019000093/primarydocument.xml","form_type":"4"}},{"id":3739290,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-07T16:07:44.000Z","date":"2018-12-07","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested as to 25% of the shares on December 21, 2016, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":10333,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001562180-18-004886","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/primarydocument.xml","form_type":"4"}},{"id":3739289,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-12-07T16:07:44.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":1666,"derivative":{"exercise_price":0.39,"expiration_date":"2024-07-11","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-004886","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/primarydocument.xml","form_type":"4"}},{"id":3739288,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-12-07T16:07:44.000Z","date":"2018-12-07","kind":"exercise","acquired":true,"shares":2000,"price":3.72,"value":7440.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001562180-18-004886","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/primarydocument.xml","form_type":"4"}},{"id":3739287,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-12-07T16:07:44.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":750,"price":34,"value":25500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001562180-18-004886","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/primarydocument.xml","form_type":"4"}},{"id":3739286,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-12-07T16:07:44.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001562180-18-004886","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004886/primarydocument.xml","form_type":"4"}},{"id":3771349,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-11-07T18:15:31.000Z","date":"2018-11-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":2416,"derivative":{"exercise_price":0.39,"expiration_date":"2024-07-11","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-004453","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004453/primarydocument.xml","form_type":"4"}},{"id":3771348,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-11-07T18:15:31.000Z","date":"2018-11-05","kind":"sale","acquired":false,"shares":750,"price":41.38,"value":31035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001562180-18-004453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004453/primarydocument.xml","form_type":"4"}},{"id":3771347,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-11-07T18:15:31.000Z","date":"2018-11-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001562180-18-004453","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004453/primarydocument.xml","form_type":"4"}},{"id":3793261,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-10-10T16:45:14.000Z","date":"2018-10-08","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":3166,"derivative":{"exercise_price":0.39,"expiration_date":"2024-07-11","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-004208","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004208/primarydocument.xml","form_type":"4"}},{"id":3793260,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-10-10T16:45:14.000Z","date":"2018-10-08","kind":"sale","acquired":false,"shares":750,"price":44.52,"value":33390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001562180-18-004208","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004208/primarydocument.xml","form_type":"4"}},{"id":3793259,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-10-10T16:45:14.000Z","date":"2018-10-08","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001562180-18-004208","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018004208/primarydocument.xml","form_type":"4"}},{"id":3823016,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-09-06T16:07:14.000Z","date":"2018-09-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares underlying this option have vested."}],"balance_after":3916,"derivative":{"exercise_price":0.39,"expiration_date":"2024-07-11","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-003854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/primarydocument.xml","form_type":"4"}},{"id":3823015,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to buy)","published_at":"2018-09-06T16:07:14.000Z","date":"2018-09-05","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vested as to 25% of the shares on December 16, 2016, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":12333,"derivative":{"exercise_price":3.72,"expiration_date":"2025-12-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001562180-18-003854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/primarydocument.xml","form_type":"4"}},{"id":3823014,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-09-06T16:07:14.000Z","date":"2018-09-05","kind":"exercise","acquired":true,"shares":2000,"price":3.72,"value":7440.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001562180-18-003854","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/primarydocument.xml","form_type":"4"}},{"id":3823013,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-09-06T16:07:14.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":750,"price":59.6,"value":44700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-003854","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/primarydocument.xml","form_type":"4"}},{"id":3823012,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-09-06T16:07:14.000Z","date":"2018-09-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-003854","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003854/primarydocument.xml","form_type":"4"}},{"id":3851671,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-08-06T18:18:09.000Z","date":"2018-08-06","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested"}],"balance_after":4666,"derivative":{"exercise_price":0.39,"expiration_date":"2024-07-11","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-003499","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003499/primarydocument.xml","form_type":"4"}},{"id":3851670,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-08-06T18:18:09.000Z","date":"2018-08-06","kind":"sale","acquired":false,"shares":750,"price":50.79,"value":38092.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-003499","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003499/primarydocument.xml","form_type":"4"}},{"id":3851669,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-08-06T18:18:09.000Z","date":"2018-08-06","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-003499","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003499/primarydocument.xml","form_type":"4"}},{"id":3872308,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-07-05T15:21:33.000Z","date":"2018-07-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested"}],"balance_after":5416,"derivative":{"exercise_price":0.39,"expiration_date":"2024-07-11","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-003237","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003237/primarydocument.xml","form_type":"4"}},{"id":3872307,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-07-05T15:21:33.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":750,"price":45.66,"value":34245.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-003237","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003237/primarydocument.xml","form_type":"4"}},{"id":3872306,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-07-05T15:21:33.000Z","date":"2018-07-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-003237","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018003237/primarydocument.xml","form_type":"4"}},{"id":3904452,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-05T14:23:01.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":6166,"derivative":{"exercise_price":0.39,"expiration_date":"2024-07-11","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001562180-18-002856","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018002856/primarydocument.xml","form_type":"4"}},{"id":3904451,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-05T14:23:01.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":0,"derivative":{"exercise_price":0.39,"expiration_date":"2023-12-05","underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001562180-18-002856","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018002856/primarydocument.xml","form_type":"4"}},{"id":3904450,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-06-05T14:23:01.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":750,"price":38.77,"value":29077.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-002856","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018002856/primarydocument.xml","form_type":"4"}},{"id":3904449,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-06-05T14:23:01.000Z","date":"2018-06-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-002856","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018002856/primarydocument.xml","form_type":"4"}},{"id":3943978,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-05-07T15:04:22.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":250,"derivative":{"exercise_price":0.39,"expiration_date":"2023-12-05","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-002313","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018002313/primarydocument.xml","form_type":"4"}},{"id":3943977,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-05-07T15:04:22.000Z","date":"2018-05-07","kind":"sale","acquired":false,"shares":750,"price":45,"value":33750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-002313","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018002313/primarydocument.xml","form_type":"4"}},{"id":3943976,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-05-07T15:04:22.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-002313","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018002313/primarydocument.xml","form_type":"4"}},{"id":3968254,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-04-05T16:04:38.000Z","date":"2018-04-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":1000,"derivative":{"exercise_price":0.39,"expiration_date":"2023-12-05","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-001868","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018001868/primarydocument.xml","form_type":"4"}},{"id":3968253,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-04-05T16:04:38.000Z","date":"2018-04-05","kind":"sale","acquired":false,"shares":750,"price":37.47,"value":28102.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-001868","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018001868/primarydocument.xml","form_type":"4"}},{"id":3968252,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-04-05T16:04:38.000Z","date":"2018-04-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-001868","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018001868/primarydocument.xml","form_type":"4"}},{"id":4009864,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-03-06T16:01:22.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":1750,"derivative":{"exercise_price":0.39,"expiration_date":"2023-12-05","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-001485","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018001485/primarydocument.xml","form_type":"4"}},{"id":4009863,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-03-06T16:01:22.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":750,"price":26.55,"value":19912.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-001485","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018001485/primarydocument.xml","form_type":"4"}},{"id":4009862,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-03-06T16:01:22.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-001485","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018001485/primarydocument.xml","form_type":"4"}},{"id":4073391,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-02-06T11:00:06.000Z","date":"2018-02-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":2500,"derivative":{"exercise_price":0.39,"expiration_date":"2023-12-05","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-000626","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018000626/primarydocument.xml","form_type":"4"}},{"id":4073390,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-02-06T11:00:06.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":750,"price":22.99,"value":17242.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-000626","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018000626/primarydocument.xml","form_type":"4"}},{"id":4073389,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-02-06T11:00:06.000Z","date":"2018-02-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-000626","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018000626/primarydocument.xml","form_type":"4"}},{"id":4103944,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-01-08T09:42:04.000Z","date":"2018-01-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":3250,"derivative":{"exercise_price":0.39,"expiration_date":"2023-12-05","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001562180-18-000248","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018000248/primarydocument.xml","form_type":"4"}},{"id":4103943,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-01-08T09:42:04.000Z","date":"2018-01-05","kind":"sale","acquired":false,"shares":750,"price":19.96,"value":14970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-18-000248","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018000248/primarydocument.xml","form_type":"4"}},{"id":4103942,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Common Stock","published_at":"2018-01-08T09:42:04.000Z","date":"2018-01-05","kind":"exercise","acquired":true,"shares":750,"price":0.39,"value":292.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001562180-18-000248","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018000248/primarydocument.xml","form_type":"4"}},{"id":4106675,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":32643,"kind":"person","name":"Moses Jennifer K.","position":1,"cik":"0001706667","reported_name":"Moses Jennifer K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance & Admin"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-01-04T09:40:13.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% of the shares on January 02, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":20.49,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-18-000171","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560241/000156218018000171/primarydocument.xml","form_type":"4"}}]}